Current data has a 15-minute delay. Please / to get real-time quotes.
icon

Annovis Bio

ANVS

ANVS Annovis Bio NYSE
Add to watchlist
169.03
0.00 (0.00 %)
At close : Jan 03, 16:00 ET
--
  • Post market
  • 20:00 ET
    Summary
    Options
    Financials
    News
    Filings
    Profile
    ANVS Chart
    See on advanced chart >
    • Volume --
    • Turnover --
    • P/E(TTM) --
    • Turnover % --
    • P/E(Static) --
    • Market Cap --
    • P/B --
    • Shares --
    • 52 Week Range
    • Day Range

    About

    Annovis Bio, Inc. was incorporated on April 29, 2008, under the laws of the State of Delaware. Annovis is a clinical stage pharmaceutical company focused on developing and commercializing innovative drugs for the treatment of Parkinson's ("PD") and...
    • Highlight
      A clinical-stage biotech company developing novel treatments for neurodegenerative diseases using its proprietary peptide-based technology
    • Industry
    • Exchange
      NYSE
    • Listing Date
      11/18/2021
    • Established Date
      04/29/2008
    • Full-time Employees
      6
    • Address
      101 Lindenwood Drive Suite 225 Malvern PA 19355
    • Tel
      1-484-8753192
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock

    Option Block Monitor

    You Can Understand Stocks with AI.
    Why NVDA surged 16.40%?
    Because it
    fork
    logo
    AInvest
    Aime Coplilot
    Invest Smarter With AI Power.
    Open App